Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 6710278, 21 pages
https://doi.org/10.1155/2017/6710278
Review Article

Advanced Role of Neutrophils in Common Respiratory Diseases

1Institute of Frontier Medical Science, Jilin University, Changchun 130021, China
2Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China
3Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China

Correspondence should be addressed to Fang Wang; nc.ude.ulj@fw

Received 1 February 2017; Revised 22 March 2017; Accepted 16 April 2017; Published 15 May 2017

Academic Editor: Michael Schnoor

Copyright © 2017 Jinping Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. F. Chung, “Targeting the interleukin pathway in the treatment of asthma,” Lancet, vol. 386, no. 9998, pp. 1086–1096, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Burney, S. Suissa, J. B. Soriano et al., “The pharmacoepidemiology of COPD: recent advances and methodological discussion,” The European Respiratory Journal. Supplement, vol. 43, no. 43, pp. 1s–44s, 2003. View at Google Scholar
  4. S. T. Gohy, C. Hupin, C. Pilette, and M. Z. Ladjemi, “Chronic inflammatory airway diseases: The central role of the epithelium revisited,” Clinical and Experimental Allergy, vol. 46, no. 4, pp. 529–542, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. J. G. Bartlett, S. F. Dowell, L. A. Mandell, T. M. File Jr, D. M. Musher, and M. J. Fine, “Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 31, no. 2, pp. 347–382, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Ekstrom and A. Bornefalk-Hermansson, “Cardiovascular and antacid treatment and mortality in oxygen-dependent pulmonary fibrosis: A population-based longitudinal study,” Respirology, vol. 21, no. 4, pp. 705–711, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Mangi, V. Bansal, G. Li, M. S. Pieper, O. Gajic, and E. Festic, “Pre-hospital use of inhaled corticosteroids and inhaled beta agonists and incidence of ARDS: a population-based study,” Acta Medica Academica, vol. 44, no. 2, pp. 109–116, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Masieri, C. Cavaliere, E. Begvarfaj, D. Rosati, and A. Minni, “Effects of omalizumab therapy on allergic rhinitis: a pilot study,” European Review for Medical and Pharmacological Sciences, vol. 20, no. 24, pp. 5249–5255, 2016. View at Google Scholar
  9. X. F. Xu, H. P. Dai, Y. M. Li, F. Xiao, and C. Wang, “Mass spectrometry-based proteomics in acute respiratory distress syndrome: a powerful modality for pulmonary precision medicine,” Chinese Medical Journal, vol. 129, no. 19, pp. 2357–2364, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Perri, E. Gianchecchi, R. Scarpa et al., “Altered B cell homeostasis and Toll-like receptor 9-driven response in patients affected by autoimmune polyglandular syndrome type 1: Altered B cell phenotype and dysregulation of the B cell function in APECED patients,” Immunobiology, vol. 222, no. 2, pp. 372–383, 2017. View at Publisher · View at Google Scholar
  11. C. Cardamone, R. Parente, G. D. Feo, and M. Triggiani, “Mast cells as effector cells of innate immunity and regulators of adaptive immunity,” Immunology Letters, vol. 178, pp. 10–14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Marchalonis, S. Kaveri, S. Lacroix-Desmazes, and M. D. Kazatchkine, “Natural recognition repertoire and the evolutionary emergence of the combinatorial immune system,” The FASEB Journal, vol. 16, no. 8, pp. 842–8, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Ginaldi, M. De Martinis, A. D'Ostilio, L. Marini, M. F. Loreto, and D. Quaglino, “The immune system in the elderly: III. Innate immunity,” Immunologic Research, vol. 20, no. 2, pp. 117–126, 1999. View at Google Scholar
  14. H. Li, T. Yang, F. Y. Li, Q. Ning, and Z. M. Sun, “TLR4 Overexpression inhibits endothelial PAS domain-containing protein 1 expression in the lower respiratory tract of patients with chronic COPD,” Cellular Physiology and Biochemistry, vol. 39, no. 2, pp. 685–692, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. K. W. Chen, J. S. Bezbradica, C. J. Gross et al., “The murine neutrophil NLRP3 inflammasome is activated by soluble but not particulate or crystalline agonists,” European Journal of Immunology, vol. 46, no. 4, pp. 1004–1010, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Ren, L. Hua, X. Meng et al., “Correlation of surface Toll-like receptor 9 expression with IL-17 production in neutrophils during septic peritonitis in mice induced by E. coli,” Mediators of Inflammation, vol. 2016, Article ID 3296307, 17 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. J. J. Eastman, K. J. Cavagnero, A. S. Deconde et al., “Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease,” The Journal of Allergy and Clinical Immunology, 2017, [Epub ahead of print]. View at Publisher · View at Google Scholar
  18. D. L. Riegert-Johnson, J. A. Godfrey, J. L. Myers, R. D. Hubmayr, W. J. Sandborn, and E. V. Loftus Jr, “Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusion,” Inflammatory Bowel Diseases, vol. 8, no. 3, pp. 186–191, 2002. View at Publisher · View at Google Scholar
  19. T. A. Gheita, H. A. Gheita, and S. A. Kenawy, “Rituximab restored the muscle power and rescued from a refractory fatal respiratory failure in a patient with elderly-onset polymyositis,” Joint, Bone, Spine, vol. 79, no. 1, pp. 101-102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. F. M. Konrad, S. Braun, K. C. Ngamsri, I. Vollmer, and J. Reutershan, “Heme oxygenase-1 attenuates acute pulmonary inflammation by decreasing the release of segmented neutrophils from the bone marrow,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 307, no. 9, pp. L707–L717, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Rosales, N. Demaurex, C. A. Lowell, and E. Uribe-Querol, “Neutrophils: Their role in innate and adaptive immunity,” Journal of Immunology Research, vol. 2016, Article ID 1469780, 2 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Liu, S. Liu, M. Verma et al., “Mechanism of TH2/TH17-predominant and neutrophilic TH2/TH17-low subtypes of asthma,” The Journal of Allergy and Clinical Immunology, 2016, [Epub ahead of print]. View at Publisher · View at Google Scholar · View at Scopus
  23. C. J. Gordon, P. M. Phillips, A. Ledbetter et al., “Active vs. sedentary lifestyle from weaning to adulthood and susceptibility to ozone in rats,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 312, no. 1, pp. L100–L109, 2017. View at Publisher · View at Google Scholar
  24. A. Vargas, F. Roux-Dalvai, A. Droit, and J. P. Lavoie, “Neutrophil-derived exosomes: a new mechanism contributing to airway smooth muscle remodeling,” American Journal of Respiratory Cell and Molecular Biology, vol. 55, no. 3, pp. 450–461, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. D. L. Pham, G. Y. Ban, S. H. Kim et al., “Neutrophil autophagy and extracellular DNA traps contribute to airway inflammation in severe asthma,” Clinical and Experimental Allergy, vol. 47, no. 1, pp. 57–70, 2017. View at Publisher · View at Google Scholar
  26. Global Initiative for Asthma, Global Strategy for Asthma Management and Prevention, GINA, Fontana, WI, USA, 2017, http://ginasthma.org/download/317/.
  27. F. Wang, X. Y. He, K. J. Baines et al., “Different inflammatory phenotypes in adults and children with acute asthma,” The European Respiratory Journal, vol. 38, no. 3, pp. 567–574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. D. B. Khatry, D. L. Gossage, G. P. Geba et al., “Discriminating sputum-eosinophilic asthma: accuracy of cutoffs in blood eosinophil measurements versus a composite index, ELEN,” The Journal of Allergy and Clinical Immunology, vol. 136, no. 3, pp. 812–814 e2, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. J. L. Simpson, R. Scott, M. J. Boyle, and P. G. Gibson, “Inflammatory subtypes in asthma: assessment and identification using induced sputum,” Respirology, vol. 11, no. 1, pp. 54–61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kupczyk, B. Dahlen, P. J. Sterk et al., “Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma,” Allergy, vol. 69, no. 9, pp. 1198–1204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Fleming, L. Tsartsali, N. Wilson, N. Regamey, and A. Bush, “Sputum inflammatory phenotypes are not stable in children with asthma,” Thorax, vol. 67, no. 8, pp. 675–681, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. T. Al-Samri, A. Benedetti, D. Prefontaine et al., “Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: a prospective study using multiple samples,” The Journal of Allergy and Clinical Immunology, vol. 125, no. 5, pp. 1161–1163.e4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Wang, P. Gao, X. Wu et al., “Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma,” Respiratory Research, vol. 17, no. 1, p. 153, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Collisson, L. Griggs, and Y. Drechsler, “Macrophages from disease resistant B2 haplotype chickens activate T lymphocytes more effectively than macrophages from disease susceptible B19 birds,” Developmental and Comparative Immunology, vol. 67, pp. 249–256, 2017. View at Publisher · View at Google Scholar
  35. S. Vedel-Krogh, S. Fallgaard Nielsen, P. Lange, J. Vestbo, and B. G. Nordestgaard, “Association of blood eosinophil and blood neutrophil counts with asthma exacerbations in the Copenhagen general population study,” Clinical Chemistry, vol. 63, no. 4, pp. 823–832, 2017. View at Publisher · View at Google Scholar
  36. E. M. Uribe Echevarria, C. A. Maldonado, A. M. Uribe Echevarria, and A. Aoki, “Neutrophil predominance in induced sputum from asthmatic patients. Therapeutic implications and role of clara cell 16-KD protein,” Medicina, vol. 71, no. 4, pp. 343–349, 2011. View at Google Scholar
  37. A. Beigelman, G. M. Weinstock, and L. B. Bacharier, “The relationships between environmental bacterial exposure, airway bacterial colonization, and asthma,” Current Opinion in Allergy and Clinical Immunology, vol. 14, no. 2, pp. 137–142, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. B. J. Green, S. Wiriyachaiporn, C. Grainge et al., “Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma,” PloS One, vol. 9, no. 6, article e100645, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A. T. Essilfie, J. L. Simpson, J. C. Horvat et al., “Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease,” PLoS Pathogens, vol. 7, no. 10, article e1002244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Alam, J. Good, D. Rollins et al., “Airway and serum biochemical correlates of refractory neutrophilic asthma,” The Journal of Allergy and Clinical Immunology, 2017, [Epub ahead of print]. View at Publisher · View at Google Scholar
  41. S. Hadebe, F. Kirstein, K. Fierens et al., “Microbial ligand costimulation drives neutrophilic steroid-refractory asthma,” PloS One, vol. 10, no. 8, article e0134219, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Ito, K. Hirose, A. Norimoto et al., “Dectin-1 plays an important role in house dust mite-induced allergic airway inflammation through the activation of CD11b+ dendritic cells,” Journal of Immunology, vol. 198, no. 1, pp. 61–70, 2017. View at Publisher · View at Google Scholar
  43. T. Mosca, M. C. Menezes, A. V. Silva, R. Stirbulov, and W. C. Forte, “Chemotactic and phagocytic activity of blood neutrophils in allergic asthma,” Immunological Investigations, vol. 44, no. 5, pp. 509–520, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Lavinskiene, J. Jeroch, K. Malakauskas, I. Bajoriuniene, J. Jackute, and R. Sakalauskas, “Peripheral blood neutrophil activity during Dermatophagoides pteronyssinus-induced late-phase airway inflammation in patients with allergic rhinitis and asthma,” Inflammation, vol. 35, no. 4, pp. 1600–1609, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Q. Siew, S. Y. Wu, S. Ying, and C. J. Corrigan, “Cigarette smoking increases bronchial mucosal IL-17A expression in asthmatics, which acts in concert with environmental aeroallergens to engender neutrophilic inflammation,” Clinical and Experimental Allergy, 2017, [Epub ahead of print]. View at Publisher · View at Google Scholar
  46. Y. Kobayashi, H. Wada, C. Rossios et al., “A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition,” British Journal of Pharmacology, vol. 169, no. 5, pp. 1024–1034, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. D. C. Newcomb, U. S. Sajjan, D. R. Nagarkar et al., “Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 10, pp. 1111–1121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Xu, N. Gera, H. Li et al., “GPCR-mediated PLCbetagamma/PKCbeta/PKD signaling pathway regulates the cofilin phosphatase slingshot 2 in neutrophil chemotaxis,” Molecular Biology of the Cell, vol. 26, no. 5, pp. 874–886, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Doukas, L. Eide, K. Stebbins et al., “Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease,” The Journal of Pharmacology and Experimental Therapeutics, vol. 328, no. 3, pp. 758–765, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. T. M. Randis, K. D. Puri, H. Zhou, and T. G. Diacovo, “Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils,” European Journal of Immunology, vol. 38, no. 5, pp. 1215–1224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. W. P. Fung-Leung, “Phosphoinositide 3-kinase delta (PI3Kdelta) in leukocyte signaling and function,” Cellular Signalling, vol. 23, no. 4, pp. 603–608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Thomas, M. J. Edwards, E. Sawicka et al., “Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammation,” Immunology, vol. 126, no. 3, pp. 413–422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Sriskantharajah, N. Hamblin, S. Worsley, A. R. Calver, E. M. Hessel, and A. Amour, “Targeting phosphoinositide 3-kinase delta for the treatment of respiratory diseases,” Annals of the new York Academy of Sciences, vol. 1280, no. 1, pp. 35–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Y. Kim, J. C. Horvat, J. W. Pinkerton et al., “MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2,” The Journal of Allergy and Clinical Immunology, vol. 139, no. 2, pp. 519–532, 2017. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Gupta, A. Khan, A. Higham et al., “The effect of phosphatidylinositol-3 kinase inhibition on matrix metalloproteinase-9 and reactive oxygen species release from chronic obstructive pulmonary disease neutrophils,” International Immunopharmacology, vol. 35, pp. 155–162, 2016. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Milara, J. Lluch, P. Almudever, J. Freire, Q. Xiaozhong, and J. Cortijo, “Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease,” The Journal of Allergy and Clinical Immunology, vol. 134, no. 2, pp. 314–322, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. Z. Dong, L. Xiong, W. Zhang et al., “Holding the inflammatory system in check: TLRs and their targeted therapy in asthma,” Mediators of Inflammation, vol. 2016, Article ID 2180417, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. B. J. Hsia, G. S. Whitehead, S. Y. Thomas et al., “Trif-dependent induction of Th17 immunity by lung dendritic cells,” Mucosal Immunology, vol. 8, no. 1, pp. 186–197, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Zhu, S. D. Message, Y. Qiu et al., “Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma,” Chest, vol. 145, no. 6, pp. 1219–1229, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. F. S. Tang, D. Van Ly, K. Spann et al., “Differential neutrophil activation in viral infections: enhanced TLR-7/8-mediated CXCL8 release in asthma,” Respirology, vol. 21, no. 1, pp. 172–179, 2016. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Hosoki, S. Ying, C. Corrigan et al., “Analysis of a panel of 48 cytokines in BAL fluids specifically identifies IL-8 levels as the only cytokine that distinguishes controlled asthma from uncontrolled asthma, and correlates inversely with FEV1,” PloS One, vol. 10, no. 5, article e0126035, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. M. A. Panaro and V. Mitolo, “Cellular responses to FMLP challenging: a mini-review,” Immunopharmacology and Immunotoxicology, vol. 21, no. 3, pp. 397–419, 1999. View at Publisher · View at Google Scholar
  63. F. S. Tang, G. J. Foxley, P. G. Gibson, J. K. Burgess, K. J. Baines, and B. G. Oliver, “Altered innate immune responses in neutrophils from patients with well- and suboptimally controlled asthma,” Mediators of Inflammation, vol. 2015, Article ID 219374, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Page, K. M. Lierl, V. S. Hughes, P. Zhou, J. R. Ledford, and M. Wills-Karp, “TLR2-mediated activation of neutrophils in response to German cockroach frass,” Journal of Immunology, vol. 180, no. 9, pp. 6317–6324, 2008. View at Publisher · View at Google Scholar
  65. K. Hosoki, T. Itazawa, I. Boldogh, and S. Sur, “Neutrophil recruitment by allergens contribute to allergic sensitization and allergic inflammation,” Current Opinion in Allergy and Clinical Immunology, vol. 16, no. 1, pp. 45–50, 2016. View at Publisher · View at Google Scholar · View at Scopus
  66. J. W. McAlees, G. S. Whitehead, I. T. Harley et al., “Distinct Tlr4-expressing cell compartments control neutrophilic and eosinophilic airway inflammation,” Mucosal Immunology, vol. 8, no. 4, pp. 863–873, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Uller, C. G. Persson, and J. S. Erjefalt, “Resolution of airway disease: Removal of inflammatory cells through apoptosis, egression or both?” Trends in Pharmacological Sciences, vol. 27, no. 9, pp. 461–466, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. K. J. Baines, J. L. Simpson, R. J. Scott, and P. G. Gibson, “Immune responses of airway neutrophils are impaired in asthma,” Experimental Lung Research, vol. 35, no. 7, pp. 554–569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. K. J. Baines, J. L. Simpson, N. A. Bowden, R. J. Scott, and P. G. Gibson, “Differential gene expression and cytokine production from neutrophils in asthma phenotypes,” The European Respiratory Journal, vol. 35, no. 3, pp. 522–531, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. J. L. Simpson, H. Powell, M. J. Boyle, R. J. Scott, and P. G. Gibson, “Clarithromycin targets neutrophilic airway inflammation in refractory asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 2, pp. 148–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. K. Maneechotesuwan, S. Essilfie-Quaye, S. A. Kharitonov, I. M. Adcock, and P. J. Barnes, “Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils,” Chest, vol. 132, no. 1, pp. 98–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. P. Katavolos, C. A. Ackerley, M. E. Clark, and D. Bienzle, “Clara cell secretory protein increases phagocytic and decreases oxidative activity of neutrophils,” Veterinary Immunology and Immunopathology, vol. 139, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. O. Cote, M. E. Clark, L. Viel et al., “Secretoglobin 1A1 and 1A1A differentially regulate neutrophil reactive oxygen species production, phagocytosis and extracellular trap formation,” PloS One, vol. 9, no. 4, article e96217, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. B. P. Tian, L. X. Xia, Z. Q. Bao et al., “Bcl-2 inhibitors reduce steroid-insensitive airway inflammation,” The Journal of Allergy and Clinical Immunology, 2016, [Epub ahead of print]. View at Publisher · View at Google Scholar
  75. M. Uddin, G. Nong, J. Ward et al., “Prosurvival activity for airway neutrophils in severe asthma,” Thorax, vol. 65, no. 8, pp. 684–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. D. H. Kim, E. Choi, J. S. Lee et al., “House dust mite allergen regulates constitutive apoptosis of normal and asthmatic neutrophils via Toll-like receptor 4,” PloS One, vol. 10, no. 5, article e0125983, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. N. R. Lee, S. Y. Baek, A. Gu et al., “House dust mite allergen suppresses neutrophil apoptosis by cytokine release via PAR2 in normal and allergic lymphocytes,” Immunologic Research, vol. 64, no. 1, pp. 123–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  78. L. I. Sikkeland, H. L. Johnsen, T. B. Riste et al., “Sputum neutrophils are elevated in smelter workers, and systemic neutrophils are associated with rapid decline in FEV1,” Occupational and Environmental Medicine, vol. 73, no. 7, pp. 459–466, 2016. View at Publisher · View at Google Scholar · View at Scopus
  79. P. L. Bruijnzeel, M. Uddin, and L. Koenderman, “Targeting neutrophilic inflammation in severe neutrophilic asthma: can we target the disease-relevant neutrophil phenotype?” Journal of Leukocyte Biology, vol. 98, no. 4, pp. 549–556, 2015. View at Publisher · View at Google Scholar · View at Scopus
  80. H. A. Murad, H. S. Habib, M. M. Rafeeq, M. I. Sulaiman, A. S. Abdulrahman, and M. N. Khabaz, “Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice,” Experimental Biology and Medicine (Maywood, N.J.), vol. 242, no. 5, pp. 516–526, 2017. View at Publisher · View at Google Scholar
  81. W. Han, J. Li, H. Tang, and L. Sun, “Treatment of obese asthma in a mouse model by simvastatin is associated with improving dyslipidemia and decreasing leptin level,” Biochemical and Biophysical Research Communications, vol. 484, no. 2, pp. 396–402, 2017. View at Publisher · View at Google Scholar
  82. C. Borlone, N. Morales, C. Henriquez et al., “In vitro effects of tamoxifen on equine neutrophils,” Research in Veterinary Science, vol. 110, pp. 60–64, 2017. View at Publisher · View at Google Scholar
  83. J. H. Yu, L. Long, Z. X. Luo, and J. R. You, “Effect of PPARgamma agonist (rosiglitazone) on the secretion of Th2 cytokine in asthma mice,” Asian Pacific Journal of Tropical Medicine, vol. 10, no. 1, pp. 64–68, 2017. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Jurcevic, C. Humfrey, M. Uddin, S. Warrington, B. Larsson, and C. Keen, “The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions,” British Journal of Clinical Pharmacology, vol. 80, no. 6, pp. 1324–1336, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Wei, J. Liu, H. Zhang et al., “Ligustrazine attenuates inflammation and the associated chemokines and receptors in ovalbumine-induced mouse asthma model,” Environmental Toxicology and Pharmacology, vol. 46, pp. 55–61, 2016. View at Publisher · View at Google Scholar · View at Scopus
  86. C. J. Liou, Y. L. Huang, W. C. Huang, K. W. Yeh, T. Y. Huang, and C. F. Lin, “Water extract of Helminthostachys zeylanica attenuates LPS-induced acute lung injury in mice by modulating NF-kappaB and MAPK pathways,” Journal of Ethnopharmacology, vol. 199, pp. 30–38, 2017. View at Publisher · View at Google Scholar
  87. Y. H. Kim, Y. J. Choi, M. K. Kang et al., “Astragalin inhibits allergic inflammation and airway thickening in ovalbumin-challenged mice,” Journal of Agricultural and Food Chemistry, vol. 65, no. 4, pp. 836–845, 2017. View at Publisher · View at Google Scholar
  88. D. A. de Almeida, S. I. Rosa, T. C. da Cruz et al., “Mandevilla Longiflora (Desf.) Pichon improves airway inflammation in a murine model of allergic asthma,” Journal of Ethnopharmacology, vol. 200, pp. 51–59, 2017. View at Publisher · View at Google Scholar
  89. Z. Zhakeer, M. Hadeer, Z. Tuerxun, and K. Tuerxun, “Bufalin inhibits the inflammatory effects in asthmatic mice through the suppression of nuclear factor-kappa B activity,” Pharmacology, vol. 99, no. 3-4, pp. 179–187, 2017. View at Publisher · View at Google Scholar
  90. X. Fei, X. Zhang, G. Q. Zhang et al., “Cordycepin inhibits airway remodeling in a rat model of chronic asthma,” Biomedicine & Pharmacotherapy, vol. 88, pp. 335–341, 2017. View at Publisher · View at Google Scholar
  91. J. D. de Boer, M. Berger, C. J. Majoor et al., “Activated protein C inhibits neutrophil migration in allergic asthma: a randomised trial,” The European Respiratory Journal, vol. 46, no. 6, pp. 1636–1644, 2015. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Liu, H. Zhang, R. Ni, W. Q. Jia, and Y. Y. Wang, “IL-4R suppresses airway inflammation in bronchial asthma by inhibiting the IL-4/STAT6 pathway,” Pulmonary Pharmacology & Therapeutics, vol. 43, pp. 32–38, 2017. View at Publisher · View at Google Scholar
  93. M. Meijer, G. T. Rijkers, and F. J. van Overveld, “Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease,” Expert Review of Clinical Immunology, vol. 9, no. 11, pp. 1055–1068, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. R. Farah, R. Ibrahim, M. Nassar, D. Najib, Y. Zivony, and E. Eshel, “Neutrophil lymphocyte ratio better addition to CRP than CD64 index as marker for infection in COPD,” Panminerva Medica, 2017, [Epub ahead of print]. View at Publisher · View at Google Scholar
  95. A. Guillon, Y. Jouan, D. Brea et al., “Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence,” The European Respiratory Journal, vol. 46, no. 3, pp. 771–782, 2015. View at Publisher · View at Google Scholar · View at Scopus
  96. D. L. Bratton and P. M. Henson, “Neutrophil clearance: when the party is over, clean-up begins,” Trends in Immunology, vol. 32, no. 8, pp. 350–357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. R. Siva, M. Bafadhel, W. Monteiro, C. E. Brightling, and I. D. Pavord, “Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 9, pp. 179–186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. S. M. Francis, M. E. Tan, P. R. Fung et al., “Peripheral compartment innate immune response to Haemophilus influenzae and Streptococcus pneumoniae in chronic obstructive pulmonary disease patients,” Innate Immunity, vol. 19, no. 4, pp. 428–437, 2013. View at Publisher · View at Google Scholar · View at Scopus
  99. J. Guiot, M. Henket, J. L. Corhay, C. Moermans, and R. Louis, “Sputum biomarkers in IPF: evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7,” PloS One, vol. 12, no. 2, article e0171344, 2017. View at Publisher · View at Google Scholar
  100. N. Noda, K. Matsumoto, S. Fukuyama et al., “Cigarette smoke impairs phagocytosis of apoptotic neutrophils by alveolar macrophages via inhibition of the histone deacetylase/Rac/CD9 pathways,” International Immunology, vol. 25, no. 11, pp. 643–650, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. T. Victoni, T. Gicquel, A. Bodin et al., “Roflumilast n-oxide associated with PGE2 prevents the neutrophil elastase-induced production of chemokines by epithelial cells,” International Immunopharmacology, vol. 30, pp. 1–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  102. D. Stolz, D. J. Leeming, J. H. Kristensen et al., “Systemic biomarkers of collagen and elastin turnover are associated with clinically relevant outcomes in COPD,” Chest, vol. 151, no. 1, pp. 47–59, 2017. View at Publisher · View at Google Scholar
  103. A. R. Bihlet, M. A. Karsdal, J. M. Sand et al., “Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD,” Respiratory Research, vol. 18, no. 1, p. 22, 2017. View at Publisher · View at Google Scholar
  104. P. Geraghty, E. Eden, M. Pillai, M. Campos, N. G. McElvaney, and R. F. Foronjy, “alpha1-antitrypsin activates protein phosphatase 2A to counter lung inflammatory responses,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 11, pp. 1229–1242, 2014. View at Publisher · View at Google Scholar · View at Scopus
  105. I. H. Heijink, S. D. Pouwels, C. Leijendekker et al., “Cigarette smoke-induced damage-associated molecular pattern release from necrotic neutrophils triggers proinflammatory mediator release,” American Journal of Respiratory Cell and Molecular Biology, vol. 52, no. 5, pp. 554–562, 2015. View at Publisher · View at Google Scholar · View at Scopus
  106. S. D. Pouwels, W. H. van Geffen, M. R. Jonker, H. A. Kerstjens, M. C. Nawijn, and I. H. Heijink, “Increased neutrophil expression of pattern recognition receptors during COPD exacerbations,” Respirology, vol. 22, no. 2, pp. 401–404, 2017. View at Publisher · View at Google Scholar · View at Scopus
  107. I. Sabroe, S. K. Dower, and M. K. Whyte, “The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis,” Clinical Infectious Diseases, vol. 41 Supplement 7, pp. S421–S426, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. I. Sabroe and M. K. Whyte, “Toll-like receptor (TLR)-based networks regulate neutrophilic inflammation in respiratory disease,” Biochemical Society Transactions, vol. 35, no. Part 6, pp. 1492–1495, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. A. Strassburg, A. Luers, and K. Dalhoff, “Decreased apoptosis of pulmonary PMN in COPD patients with community-acquired pneumonia,” The Clinical Respiratory Journal, vol. 4, no. 2, pp. 111–119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. E. Mortaz, I. M. Adcock, K. Ito, A. D. Kraneveld, F. P. Nijkamp, and G. Folkerts, “Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor,” The European Respiratory Journal, vol. 36, no. 5, pp. 1143–1154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. K. Guzik, J. Skret, J. Smagur et al., “Cigarette smoke-exposed neutrophils die unconventionally but are rapidly phagocytosed by macrophages,” Cell Death & Disease, vol. 2, article e131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. F. Pedersen, S. Marwitz, O. Holz et al., “Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients,” Respiratory Medicine, vol. 109, no. 10, pp. 1360–1362, 2015. View at Publisher · View at Google Scholar · View at Scopus
  113. K. A. Stringer, M. Tobias, H. C. O'Neill, and C. C. Franklin, “Cigarette smoke extract-induced suppression of caspase-3-like activity impairs human neutrophil phagocytosis,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 292, no. 6, pp. L1572–L1579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. V. Brown, J. S. Elborn, J. Bradley, and M. Ennis, “Dysregulated apoptosis and NFkappaB expression in COPD subjects,” Respiratory Research, vol. 10, no. 1, p. 24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  115. D. Makris, T. Vrekoussis, M. Izoldi et al., “Increased apoptosis of neutrophils in induced sputum of COPD patients,” Respiratory Medicine, vol. 103, no. 8, pp. 1130–1135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. A. Obermayer, W. Stoiber, W. D. Krautgartner et al., “New aspects on the structure of neutrophil extracellular traps from chronic obstructive pulmonary disease and in vitro generation,” PloS One, vol. 9, no. 5, article e97784, 2014. View at Publisher · View at Google Scholar · View at Scopus
  117. V. Brinkmann, U. Reichard, C. Goosmann et al., “Neutrophil extracellular traps kill bacteria,” Science, vol. 303, no. 5663, pp. 1532–1535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. R. Anderson, A. J. Theron, H. C. Steel, C. Durandt, G. R. Tintinger, and C. Feldman, “The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro,” Mediators of Inflammation, vol. 2014, Article ID 105420, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. N. Tanabe, Y. Hoshino, S. Marumo et al., “Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation,” PloS One, vol. 8, no. 11, article e79016, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. C. Gao, R. Fujinawa, T. Yoshida et al., “A keratan sulfate disaccharide prevents inflammation and the progression of emphysema in murine models,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 312, no. 2, pp. L268–L276, 2017. View at Publisher · View at Google Scholar
  121. L. I. Kunz, N. H. Ten Hacken, T. S. Lapperre et al., “Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids,” The European Respiratory Journal, vol. 49, no. 1, 2017. View at Publisher · View at Google Scholar
  122. Y. Lei, Y. Gao, J. Chen et al., “GLCCI1 rs37973: a potential genetic predictor of therapeutic response to inhaled corticosteroids in Chinese chronic obstructive pulmonary disease patients,” Scientific Reports, vol. 7, p. 42552, 2017. View at Publisher · View at Google Scholar
  123. B. Park, G. Park, J. Kim, S. A. Lim, and K. M. Lee, “Innate immunity against Legionella pneumophila during pulmonary infections in mice,” Archives of Pharmacal Research, vol. 40, no. 2, pp. 131–145, 2017. View at Publisher · View at Google Scholar
  124. Y. Onishi, T. Kawamura, Y. Nakahara et al., “Factors associated with the relapse of cryptogenic and secondary organizing pneumonia,” Respiratory Investigation, vol. 55, no. 1, pp. 10–15, 2017. View at Publisher · View at Google Scholar
  125. S. Patamatamkul, V. Klungboonkrong, P. Praisarnti, and K. Jirakiat, “A case-control study of community-acquired Acinetobacter baumannii pneumonia and melioidosis pneumonia in northeast Thailand: an emerging fatal disease with unique clinical features,” Diagnostic Microbiology and Infectious Disease, vol. 87, no. 1, pp. 79–86, 2017. View at Publisher · View at Google Scholar
  126. R. Farah, J. Bleier, P. Gilbey, and R. Khamisy-Farah, “Common laboratory parameters for differentiating between community-acquired and healthcare-associated pneumonia,” Journal of Clinical Laboratory Analysis, vol. 31, no. 1, 2017. View at Publisher · View at Google Scholar · View at Scopus
  127. P. R. Secor, L. A. Michaels, K. S. Smigiel et al., “Filamentous bacteriophage produced by Pseudomonas aeruginosa alters the inflammatory response and promotes noninvasive infection in vivo,” Infection and Immunity, vol. 85, no. 1, 2017. View at Publisher · View at Google Scholar
  128. V. S. Patel, R. A. Sitapara, A. Gore et al., “High mobility group box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 48, no. 3, pp. 280–287, 2013. View at Publisher · View at Google Scholar · View at Scopus
  129. Y. W. Yang, Y. Z. Jiang, C. M. Hsu, and L. W. Chen, “Pseudomonas aeruginosa ventilator-associated pneumonia induces lung injury through TNF-alpha/c-Jun NH2-terminal Kinase pathways,” PloS One, vol. 12, no. 1, article e0169267, 2017. View at Publisher · View at Google Scholar
  130. Z. Piao, H. Yuan, C. Wang, and L. Shi, “IRF3 inhibits neutrophil recruitment in mice infected with Pseudomonas aeruginosa,” Inflammation, 2017, [Epub ahead of print]. View at Publisher · View at Google Scholar
  131. A. Antonelli, S. Di Maggio, J. Rejman et al., “The shedding-derived soluble receptor for advanced glycation endproducts sustains inflammation during acute Pseudomonas aeruginosa lung infection,” Biochimica et Biophysica Acta, vol. 1861, no. 2, pp. 354–364, 2017. View at Publisher · View at Google Scholar
  132. M. Entezari, D. J. Weiss, R. Sitapara et al., “Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas aeruginosa pneumonia in cystic fibrosis,” Molecular Medicine, vol. 18, pp. 477–485, 2012. View at Publisher · View at Google Scholar
  133. Z. S. Wilson, L. B. Ahn, W. S. Serratelli et al., “Activated beta2 integrins restrict neutrophil recruitment during murine acute Pseudomonal pneumonia,” American Journal of Respiratory Cell and Molecular Biology, 2017, [Epub ahead of print]. View at Publisher · View at Google Scholar
  134. R. Wilson, J. M. Cohen, R. J. Jose, C. de Vogel, H. Baxendale, and J. S. Brown, “Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses,” Mucosal Immunology, vol. 8, no. 3, pp. 627–639, 2015. View at Publisher · View at Google Scholar · View at Scopus
  135. T. J. Hommes, M. H. van Lieshout, C. van' t Veer et al., “Role of nucleotide-binding oligomerization domain-containing (NOD) 2 in host defense during pneumococcal pneumonia,” PloS One, vol. 10, no. 12, article e0145138, 2015. View at Publisher · View at Google Scholar · View at Scopus
  136. A. Bouchon, J. Dietrich, and M. Colonna, “Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes,” Journal of Immunology, vol. 164, no. 10, pp. 4991–4995, 2000. View at Publisher · View at Google Scholar
  137. M. G. Netea, T. Azam, G. Ferwerda, S. E. Girardin, S. H. Kim, and C. A. Dinarello, “Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors,” Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1454–1461, 2006. View at Publisher · View at Google Scholar · View at Scopus
  138. T. J. Hommes, A. J. Hoogendijk, M. C. Dessing et al., “Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia,” The Journal of Pathology, vol. 233, no. 4, pp. 357–367, 2014. View at Publisher · View at Google Scholar · View at Scopus
  139. M. Schouten, J. D. de Boer, L. M. Kager et al., “The endothelial protein C receptor impairs the antibacterial response in murine pneumococcal pneumonia and sepsis,” Thrombosis and Haemostasis, vol. 111, no. 5, pp. 970–980, 2014. View at Publisher · View at Google Scholar · View at Scopus
  140. H. Yang, H. J. Ko, J. Y. Yang et al., “Interleukin-1 promotes coagulation, which is necessary for protective immunity in the lung against Streptococcus pneumoniae infection,” The Journal of Infectious Diseases, vol. 207, no. 1, pp. 50–60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. D. C. Blok, M. H. van Lieshout, A. J. Hoogendijk et al., “Single immunoglobulin interleukin-1 receptor-related molecule impairs host defense during pneumonia and sepsis caused by Streptococcus pneumoniae,” Journal of Innate Immunity, vol. 6, no. 4, pp. 542–552, 2014. View at Publisher · View at Google Scholar · View at Scopus
  142. A. van Belkum, N. J. Verkaik, C. P. de Vogel et al., “Reclassification of Staphylococcus aureus nasal carriage types,” The Journal of Infectious Diseases, vol. 199, no. 12, pp. 1820–1826, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. S. Y. Tong, J. S. Davis, E. Eichenberger, T. L. Holland, and V. G. Fowler Jr, “Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management,” Clinical Microbiology Reviews, vol. 28, no. 3, pp. 603–661, 2015. View at Publisher · View at Google Scholar · View at Scopus
  144. C. K. Naber, “Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies,” Clinical Infectious Diseases, vol. 48 Supplement 4, pp. S231–S237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  145. E. A. Fitzpatrick, D. You, B. Shrestha et al., “A neonatal murine model of MRSA pneumonia,” PloS One, vol. 12, no. 1, article e0169273, 2017. View at Publisher · View at Google Scholar
  146. T. Kantyka, K. Pyrc, M. Gruca et al., “Staphylococcus aureus proteases degrade lung surfactant protein A potentially impairing innate immunity of the lung,” Journal of Innate Immunity, vol. 5, no. 3, pp. 251–260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  147. K. Dietert, K. Reppe, L. Mundhenk, M. Witzenrath, and A. D. Gruber, “mCLCA3 modulates IL-17 and CXCL-1 induction and leukocyte recruitment in murine Staphylococcus aureus pneumonia,” PloS One, vol. 9, no. 7, article e102606, 2014. View at Publisher · View at Google Scholar · View at Scopus
  148. A. Sharma, A. L. Steichen, C. N. Jondle, B. B. Mishra, and J. Sharma, “Protective role of Mincle in bacterial pneumonia by regulation of neutrophil mediated phagocytosis and extracellular trap formation,” The Journal of Infectious Diseases, vol. 209, no. 11, pp. 1837–1846, 2014. View at Publisher · View at Google Scholar · View at Scopus
  149. Y. Miyake, E. Ishikawa, T. Ishikawa, and S. Yamasaki, “Self and nonself recognition through C-type lectin receptor, Mincle,” Self Nonself, vol. 1, no. 4, pp. 310–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  150. C. N. Jondle, A. Sharma, T. J. Simonson, B. Larson, B. B. Mishra, and J. Sharma, “Macrophage galactose-type lectin-1 deficiency is associated with increased neutrophilia and hyperinflammation in gram-negative pneumonia,” Journal of Immunology, vol. 196, no. 7, pp. 3088–3096, 2016. View at Publisher · View at Google Scholar · View at Scopus
  151. S. Cai, S. Batra, N. Wakamatsu, P. Pacher, and S. Jeyaseelan, “NLRC4 inflammasome-mediated production of IL-1beta modulates mucosal immunity in the lung against gram-negative bacterial infection,” Journal of Immunology, vol. 188, no. 11, pp. 5623–5635, 2012. View at Publisher · View at Google Scholar · View at Scopus
  152. A. Achouiti, T. Vogl, C. F. Urban et al., “Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsis,” PLoS Pathogens, vol. 8, no. 10, article e1002987, 2012. View at Publisher · View at Google Scholar · View at Scopus
  153. B. J. Wolff, A. J. Benitez, H. P. Desai, S. S. Morrison, M. H. Diaz, and J. M. Winchell, “Development of a multiplex taqMan real-time PCR assay for typing of mycoplasma pneumoniae based on type-specific indels identified through whole genome sequencing,” Diagnostic Microbiology and Infectious Disease, vol. 87, no. 3, pp. 203–206, 2017. View at Publisher · View at Google Scholar · View at Scopus
  154. H. Tanaka, “Correlation between radiological and pathological findings in patients with mycoplasma pneumoniae pneumonia,” Frontiers in Microbiology, vol. 7, p. 695, 2016. View at Publisher · View at Google Scholar · View at Scopus
  155. L. Guo, F. Liu, M. P. Lu, Q. Zheng, and Z. M. Chen, “Increased T cell activation in BALF from children with mycoplasma pneumoniae pneumonia,” Pediatric Pulmonology, vol. 50, no. 8, pp. 814–819, 2015. View at Publisher · View at Google Scholar · View at Scopus
  156. F. W. Arnold, J. Bordon, R. Fernandez-Botran et al., “Macrolide use and neutrophil function/cytokine levels in hospitalized patients with community-acquired pneumonia: a pilot study,” Lung, vol. 194, no. 1, pp. 155–162, 2016. View at Publisher · View at Google Scholar · View at Scopus
  157. P. F. Cespedes, E. Rey-Jurado, J. A. Espinoza et al., “A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice,” Vaccine, vol. 35, no. 5, pp. 757–766, 2017. View at Publisher · View at Google Scholar
  158. Q. Xu, N. Surendran, D. Verhoeven, J. Klapa, M. Ochs, and M. E. Pichichero, “Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis,” Vaccine, vol. 33, no. 8, pp. 993–1000, 2015. View at Publisher · View at Google Scholar · View at Scopus
  159. F. Pinheiro da Silva and M. C. Machado, “The dual role of cathelicidins in systemic inflammation,” Immunology Letters, vol. 182, pp. 57–60, 2017. View at Publisher · View at Google Scholar
  160. E. N. Bou Ghanem, S. Clark, X. Du et al., “The alpha-tocopherol form of vitamin E reverses age-associated susceptibility to streptococcus pneumoniae lung infection by modulating pulmonary neutrophil recruitment,” Journal of Immunology, vol. 194, no. 3, pp. 1090–1099, 2015. View at Publisher · View at Google Scholar · View at Scopus
  161. D. Cortinovis, V. Gregorc, M. R. Migliorino et al., “New perspectives in the second-line treatment of non squamous NSCLC patients: results from a large Italian lung cancer working group,” Critical Reviews in Oncology/Hematology, vol. 109, pp. 35–41, 2017. View at Publisher · View at Google Scholar
  162. X. Zhang, W. Zhang, X. Yuan, M. Fu, H. Qian, and W. Xu, “[Corrigendum] Neutrophils in cancer development and progression: roles, mechanisms, and implications (review),” International Journal of Oncology, vol. 50, no. 2, p. 745, 2017. View at Publisher · View at Google Scholar
  163. H. G. Vikis, A. E. Gelman, A. Franklin et al., “Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis,” Molecular Carcinogenesis, vol. 51, no. 12, pp. 993–1002, 2012. View at Publisher · View at Google Scholar · View at Scopus
  164. C. Xu, C. M. Fillmore, S. Koyama et al., “Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression,” Cancer Cell, vol. 25, no. 5, pp. 590–604, 2014. View at Publisher · View at Google Scholar · View at Scopus
  165. U. Meyer-Hoffert and O. Wiedow, “Neutrophil serine proteases: mediators of innate immune responses,” Current Opinion in Hematology, vol. 18, no. 1, pp. 19–24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  166. L. Chen, Q. Li, X. D. Zhou et al., “Increased pro-angiogenic factors, infiltrating neutrophils and CD163(+) macrophages in bronchoalveolar lavage fluid from lung cancer patients,” International Immunopharmacology, vol. 20, no. 1, pp. 74–80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  167. T. Yamamoto, K. Kawada, Y. Itatani et al., “Loss of SMAD4 promotes lung metastasis of colorectal cancer by accumulation of CCR1+ tumor-associated neutrophils through CCL15-CCR1 axis,” Clinical Cancer Research, vol. 23, no. 3, pp. 833–844, 2017. View at Publisher · View at Google Scholar
  168. Y. Takahashi, M. Kawamura, T. Hato, M. Harada, N. Matsutani, and H. Horio, “Neutrophil-lymphocyte ratio as a prognostic marker for lung adenocarcinoma after complete resection,” World Journal of Surgery, vol. 40, no. 2, pp. 365–372, 2016. View at Publisher · View at Google Scholar · View at Scopus
  169. L. Kasmann, L. Bolm, S. E. Schild, S. Janssen, and D. Rades, “Neutrophil-to-lymphocyte ratio predicts outcome in limited disease small-cell lung cancer,” Lung, vol. 195, no. 2, pp. 217–224, 2017. View at Publisher · View at Google Scholar
  170. L. Jiang, Z. Zhao, S. Jiang et al., “Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer,” Immunologic Research, vol. 62, no. 3, pp. 316–324, 2015. View at Publisher · View at Google Scholar · View at Scopus
  171. S. Cao, S. Jin, J. Shen et al., “Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients,” Oncotarget, vol. 8, no. 5, pp. 8657–8669, 2017. View at Publisher · View at Google Scholar
  172. E. Jeong, S. H. Hyun, S. H. Moon, Y. S. Cho, B. T. Kim, and K. H. Lee, “Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection,” Medicine (Baltimore), vol. 96, no. 5, article e5935, 2017. View at Publisher · View at Google Scholar
  173. B. A. Derman, J. N. Macklis, M. S. Azeem et al., “Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer,” BMC Cancer, vol. 17, no. 1, p. 141, 2017. View at Publisher · View at Google Scholar
  174. M. Yuste, T. Fernandez-Caballero, C. Prieto et al., “Splenic CD163+ macrophages as targets of porcine reproductive and respiratory virus: role of Siglecs,” Veterinary Microbiology, vol. 198, pp. 72–80, 2017. View at Publisher · View at Google Scholar
  175. K. Ohnishi, M. Yamaguchi, C. Erdenebaatar et al., “Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma,” Cancer Science, vol. 107, no. 6, pp. 846–852, 2016. View at Publisher · View at Google Scholar · View at Scopus
  176. H. Laubli, O. M. Pearce, F. Schwarz et al., “Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 39, pp. 14211–14216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  177. W. D. Travis, E. Brambilla, and G. J. Riely, “New pathologic classification of lung cancer: relevance for clinical practice and clinical trials,” Journal of Clinical Oncology, vol. 31, no. 8, pp. 992–1001, 2013. View at Publisher · View at Google Scholar · View at Scopus
  178. A. S. Nagaraj, J. Lahtela, A. Hemmes et al., “Cell of origin links histotype spectrum to immune microenvironment diversity in non-small-cell lung cancer driven by mutant Kras and loss of Lkb1,” Cell Reports, vol. 18, no. 3, pp. 673–684, 2017. View at Publisher · View at Google Scholar
  179. C. F. Wu, L. Andzinski, N. Kasnitz et al., “The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung,” International Journal of Cancer, vol. 137, no. 4, pp. 837–847, 2015. View at Publisher · View at Google Scholar · View at Scopus
  180. M. Kowanetz, X. Wu, J. Lee et al., “Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 50, pp. 21248–21255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  181. R. N. Kaplan, R. D. Riba, S. Zacharoulis et al., “VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche,” Nature, vol. 438, no. 7069, pp. 820–827, 2005. View at Publisher · View at Google Scholar · View at Scopus
  182. S. Hiratsuka, A. Watanabe, H. Aburatani, and Y. Maru, “Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis,” Nature Cell Biology, vol. 8, no. 12, pp. 1369–1375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  183. N. Lavender, J. Yang, S. C. Chen et al., “The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo,” BMC Cancer, vol. 17, no. 1, p. 88, 2017. View at Publisher · View at Google Scholar
  184. S. B. Coffelt, K. Kersten, C. W. Doornebal et al., “IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis,” Nature, vol. 522, no. 7556, pp. 345–348, 2015. View at Publisher · View at Google Scholar · View at Scopus
  185. T. Bald, T. Quast, J. Landsberg et al., “Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma,” Nature, vol. 507, no. 7490, pp. 109–113, 2014. View at Publisher · View at Google Scholar · View at Scopus
  186. Y. M. Abadi, H. Jeon, K. C. Ohaegbulam et al., “Host b7x promotes pulmonary metastasis of breast cancer,” Journal of Immunology, vol. 190, no. 7, pp. 3806–3814, 2013. View at Publisher · View at Google Scholar · View at Scopus
  187. C. Carbonelli, G. Rossi, and A. Cavazza, “Cryobiopsy and multidisciplinary diagnosis of idiopathic pulmonary fibrosis,” Respirology, vol. 20, no. 4, p. 685, 2015. View at Publisher · View at Google Scholar · View at Scopus
  188. R. P. Baughman and G. Raghu, “Bronchoalveolar cellular analysis in scleroderma lung disease: does Sutton’s law hold?” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 1, pp. 2-3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  189. E. J. Lammertyn, E. Vandermeulen, H. Bellon et al., “End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis,” Respiratory Research, vol. 18, no. 1, p. 10, 2017. View at Publisher · View at Google Scholar
  190. K. Rydell-Tormanen, K. Andreasson, R. Hesselstrand et al., “Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis,” Laboratory Investigation, vol. 92, no. 6, pp. 917–925, 2012. View at Publisher · View at Google Scholar · View at Scopus
  191. M. Gschwandtner, E. Strutzmann, M. M. Teixeira et al., “Glycosaminoglycans are important mediators of neutrophilic inflammation in vivo,” Cytokine, vol. 91, pp. 65–73, 2017. View at Publisher · View at Google Scholar
  192. Y. Obayashi, J. Fujita, T. Nishiyama et al., “Role of carbohydrate antigens sialyl Lewis (a) (CA19-9) in bronchoalveolar lavage in patients with pulmonary fibrosis,” Respiration, vol. 67, no. 2, pp. 146–152, 2000. View at Publisher · View at Google Scholar
  193. N. Cox, D. Pilling, and R. H. Gomer, “Serum amyloid P: a systemic regulator of the innate immune response,” Journal of Leukocyte Biology, vol. 96, no. 5, pp. 739–743, 2014. View at Publisher · View at Google Scholar · View at Scopus
  194. N. Cox, D. Pilling, and R. H. Gomer, “DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 27, pp. 8385–8390, 2015. View at Publisher · View at Google Scholar · View at Scopus
  195. N. Cox, D. Pilling, and R. H. Gomer, “Distinct Fcgamma receptors mediate the effect of serum amyloid p on neutrophil adhesion and fibrocyte differentiation,” Journal of Immunology, vol. 193, no. 4, pp. 1701–1708, 2014. View at Publisher · View at Google Scholar · View at Scopus
  196. N. Rieber, A. Hector, M. Carevic, and D. Hartl, “Current concepts of immune dysregulation in cystic fibrosis,” The International Journal of Biochemistry & Cell Biology, vol. 52, pp. 108–112, 2014. View at Publisher · View at Google Scholar · View at Scopus
  197. D. L. Forrester, H. L. Barr, A. Fogarty, and A. Knox, “sTREM-1 is elevated in cystic fibrosis and correlates with proteases,” Pediatric Pulmonology, vol. 52, no. 4, pp. 467–471, 2017. View at Publisher · View at Google Scholar
  198. J. Eckrich, U. M. Zissler, F. Serve et al., “Airway inflammation in mild cystic fibrosis,” Journal of Cystic Fibrosis, vol. 16, no. 1, pp. 107–115, 2017. View at Publisher · View at Google Scholar · View at Scopus
  199. S. A. Ingersoll, J. Laval, O. A. Forrest et al., “Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1,” Journal of Immunology, vol. 194, no. 11, pp. 5520–5528, 2015. View at Publisher · View at Google Scholar · View at Scopus
  200. S. Zheng, A. B. Kummarapurugu, D. K. Afosah et al., “2-O, 3-O desulfated heparin blocks high mobility group box 1 release by inhibition of p300 acetyltransferase activity,” American Journal of Respiratory Cell and Molecular Biology, vol. 56, no. 1, pp. 90–98, 2017. View at Publisher · View at Google Scholar
  201. B. A. Flitter, K. L. Hvorecny, E. Ono et al., “Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators,” Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 1, pp. 136–141, 2017. View at Publisher · View at Google Scholar
  202. H. P. Ng, Y. Zhou, K. Song, C. A. Hodges, M. L. Drumm, and G. Wang, “Neutrophil-mediated phagocytic host defense defect in myeloid Cftr-inactivated mice,” PloS One, vol. 9, no. 9, article e106813, 2014. View at Publisher · View at Google Scholar · View at Scopus
  203. P. Duchesneau, R. Besla, M. F. Derouet et al., “Partial restoration of CFTR function in cftr-null mice following targeted cell replacement therapy,” Molecular Therapy, vol. 25, no. 3, pp. 654–665, 2017. View at Publisher · View at Google Scholar
  204. A. Hector, M. Kormann, J. Kammermeier et al., “Expression and regulation of interferon-related development regulator-1 in cystic fibrosis neutrophils,” American Journal of Respiratory Cell and Molecular Biology, vol. 48, no. 1, pp. 71–77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  205. G. Y. Chen, C. Chen, L. Wang, X. Chang, P. Zheng, and Y. Liu, “Cutting edge: broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells,” Journal of Immunology, vol. 180, no. 8, pp. 5163–5166, 2008. View at Publisher · View at Google Scholar
  206. D. Shin, G. Lee, S. Lee et al., “Adenovirus-mediated Foxp3 expression in lung epithelial cells ameliorates acute radiation-induced pneumonitis in mice,” Gene Therapy, vol. 24, no. 2, pp. 104–112, 2017. View at Publisher · View at Google Scholar
  207. G. C. Mouradian, R. Gaurav, S. Pugliese et al., “Superoxide dismutase 3 R213G single-nucleotide polymorphism blocks murine bleomycin-induced fibrosis and promotes resolution of inflammation,” American Journal of Respiratory Cell and Molecular Biology, vol. 56, no. 3, pp. 362–371, 2017. View at Publisher · View at Google Scholar
  208. F. Yang, Y. Cao, J. Zhang, T. You, and L. Zhu, “Glaucocalyxin A improves survival in bleomycin-induced pulmonary fibrosis in mice,” Biochemical and Biophysical Research Communications, vol. 482, no. 1, pp. 147–153, 2017. View at Publisher · View at Google Scholar
  209. J. S. Elborn, A. Horsley, G. MacGregor et al., “Phase I studies of acebilustat: biomarker response and safety in patients with cystic fibrosis,” Clinical and Translational Science, vol. 10, no. 1, pp. 28–34, 2017. View at Publisher · View at Google Scholar · View at Scopus
  210. E. Hayes, K. Pohl, N. G. McElvaney, and E. P. Reeves, “The cystic fibrosis neutrophil: a specialized yet potentially defective cell,” Archivum Immunologiae et Therapiae Experimentalis (Warsz), vol. 59, no. 2, pp. 97–112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  211. E. P. Reeves, N. Banville, D. M. Ryan et al., “Intracellular secretory leukoprotease inhibitor modulates inositol 1,4,5-triphosphate generation and exerts an anti-inflammatory effect on neutrophils of individuals with cystic fibrosis and chronic obstructive pulmonary disease,” BioMed Research International, vol. 2013, p. 560141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  212. O. J. McElvaney, N. O'Reilly, M. White et al., “The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis,” Molecular Immunology, vol. 63, no. 2, pp. 550–558, 2015. View at Publisher · View at Google Scholar · View at Scopus
  213. T. G. Boyce, “More on viral bronchiolitis in children,” The New England Journal of Medicine, vol. 375, no. 12, pp. 1199-1200, 2016. View at Publisher · View at Google Scholar
  214. J. L. Simpson, S. Phipps, and P. G. Gibson, “Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis,” Pharmacology & Therapeutics, vol. 124, no. 1, pp. 86–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  215. E. C. Cavallaro, K. K. Liang, M. D. Lawrence, K. D. Forsyth, and D. L. Dixon, “Neutrophil infiltration and activation in bronchiolitic airways are independent of viral etiology,” Pediatric Pulmonology, vol. 52, no. 2, pp. 238–246, 2017. View at Publisher · View at Google Scholar
  216. D. L. Dixon, K. M. Griggs, K. D. Forsyth, and A. D. Bersten, “Lower interleukin-8 levels in airway aspirates from breastfed infants with acute bronchiolitis,” Pediatric Allergy and Immunology, vol. 21, no. 4 Pt 2, pp. e691–e696, 2010. View at Publisher · View at Google Scholar · View at Scopus
  217. E. Pace, M. Ferraro, A. Giarratano, C. Cipollina, and M. Gjomarkaj, “TLR4 up-regulation and reduced Foxp3 expression in mechanically ventilated smokers with obstructive chronic bronchitis,” Copd, vol. 10, no. 2, pp. 147–155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  218. K. Sahlander, K. Larsson, and L. Palmberg, “Altered innate immune response in farmers and smokers,” Innate Immunity, vol. 16, no. 1, pp. 27–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  219. K. Sahlander, K. Larsson, and L. Palmberg, “Daily exposure to dust alters innate immunity,” PloS One, vol. 7, no. 2, article e31646, 2012. View at Publisher · View at Google Scholar · View at Scopus
  220. W. Jiang, T. Wang, L. Li, W. Ji, Y. Wang, and Y. Yan, “Impact of bacteria in nasal aspirates on disease severity of bronchiolitis,” Infectious Diseases, vol. 48, no. 1, pp. 82–86, 2016. View at Publisher · View at Google Scholar · View at Scopus
  221. A. B. Chang, J. W. Upham, I. B. Masters et al., “Protracted bacterial bronchitis: the last decade and the road ahead,” Pediatric Pulmonology, vol. 51, no. 3, pp. 225–242, 2016. View at Publisher · View at Google Scholar · View at Scopus
  222. T. Matsumoto, M. Fujita, R. Hirano et al., “Chronic Pseudomonas aeruginosa infection-induced chronic bronchitis and emphysematous changes in CCSP-deficient mice,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 11, pp. 2321–2327, 2016. View at Publisher · View at Google Scholar · View at Scopus
  223. M. C. Suarez-Arrabal, C. Mella, S. M. Lopez et al., “Nasopharyngeal bacterial burden and antibiotics: influence on inflammatory markers and disease severity in infants with respiratory syncytial virus bronchiolitis,” The Journal of Infection, vol. 71, no. 4, pp. 458–469, 2015. View at Publisher · View at Google Scholar · View at Scopus
  224. L. A. Borthwick, M. I. Suwara, S. C. Carnell et al., “Pseudomonas aeruginosa induced airway epithelial injury drives fibroblast activation: a mechanism in chronic lung allograft dysfunction,” American Journal of Transplantation, vol. 16, no. 6, pp. 1751–1765, 2016. View at Publisher · View at Google Scholar · View at Scopus
  225. M. A. Farrag and F. N. Almajhdi, “Human respiratory syncytial virus: role of innate immunity in clearance and disease progression,” Viral Immunology, vol. 29, no. 1, pp. 11–26, 2016. View at Publisher · View at Google Scholar · View at Scopus
  226. B. Cortjens, O. J. de Boer, R. de Jong et al., “Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease,” The Journal of Pathology, vol. 238, no. 3, pp. 401–411, 2016. View at Publisher · View at Google Scholar · View at Scopus
  227. C. Schnoeller, X. Roux, D. Sawant et al., “Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism,” American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 2, pp. 194–202, 2014. View at Publisher · View at Google Scholar · View at Scopus
  228. P. M. Fisichella, C. S. Davis, E. Lowery, L. Ramirez, R. L. Gamelli, and E. J. Kovacs, “Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation,” Journal of the American College of Surgeons, vol. 217, no. 1, pp. 90–100, 2013, discussion 100-1. View at Publisher · View at Google Scholar · View at Scopus
  229. J. Eckrich, E. Herrmann, S. Voss, R. Schubert, S. Zielen, and M. Rosewich, “Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans,” Lung, vol. 194, no. 4, pp. 571–579, 2016. View at Publisher · View at Google Scholar · View at Scopus
  230. E. Vandermeulen, E. Lammertyn, S. E. Verleden et al., “Immunological diversity in phenotypes of chronic lung allograft dysfunction: a comprehensive immunohistochemical analysis,” Transplant International, vol. 30, no. 2, pp. 134–143, 2017. View at Publisher · View at Google Scholar · View at Scopus
  231. V. Tiriveedhi, M. Takenaka, N. J. Sarma, A. G. Gelman, and T. Mohanakumar, “Anti-major histocompatibility complex-induced obliterative airway disease: selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens,” The Journal of Heart and Lung Transplantation, vol. 32, no. 7, pp. 714–722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  232. V. Tiriveedhi, M. Takenaka, S. Ramachandran et al., “T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease,” American Journal of Transplantation, vol. 12, no. 10, pp. 2663–2674, 2012. View at Publisher · View at Google Scholar · View at Scopus
  233. R. Krebs, J. M. Tikkanen, J. O. Ropponen et al., “Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis,” The American Journal of Pathology, vol. 181, no. 5, pp. 1607–1620, 2012. View at Publisher · View at Google Scholar · View at Scopus
  234. J. L. Todd, X. Wang, S. Sugimoto et al., “Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity,” American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 5, pp. 556–566, 2014. View at Publisher · View at Google Scholar · View at Scopus
  235. Y. Zhao, D. J. LaPar, J. Steidle et al., “Adenosine signaling via the adenosine 2B receptor is involved in bronchiolitis obliterans development,” The Journal of Heart and Lung Transplantation, vol. 29, no. 12, pp. 1405–1414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  236. C. L. Lau, Y. Zhao, I. L. Kron et al., “The role of adenosine A2A receptor signaling in bronchiolitis obliterans,” The Annals of Thoracic Surgery, vol. 88, no. 4, pp. 1071–1078, 2009. View at Publisher · View at Google Scholar · View at Scopus